AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW BURNETT | Legislative Assistant, Office of Sen. Richard Shelby; Health Research and Policy Assistant, Senate Committee on Health, Education, Labor and Pension |
| THOMAS B SPARKMAN | — |
Medicare/Medicaid MMM
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93), H.R.791 - Tracking COVID-19 Variants Act, S.236 - Tracking COVID-19 Variants Act, H.R.533 - Stop COVID-19 Test Surprise Medical Bills Act of 2021, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW BURNETT | Legislative Assistant, Office of Sen. Richard Shelby; Health Research and Policy Assistant, Senate Committee on Health, Education, Labor and Pension |
| THOMAS B SPARKMAN | — |
Budget/Appropriations BUD
Reimbursement and coverage issues for and related to clinical laboratory services, including COVID-19 test coverage and reimbursement, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS B SPARKMAN | — |
Health Issues HCR
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS B SPARKMAN | — |
Disaster Planning/Emergencies DIS
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS B SPARKMAN | — |
Insurance INS
COVID-19 test coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS B SPARKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.